The top 10 biopharma stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Boehringer Ingelheim, Henlius, Incyte, Janssen, PTC.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biochestra, Codiak, Crispr, Everest, Firefly Neuro, Gilead, Immunomedics, Merck, Pfizer, Stalicla, Vertex.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Avalyn, Destiny, Neurelis, Relmada.

Biopharmas raising money in public or private financings, including: Arrivent, Karuna, Solascure and S.R. One.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Neurorpm, Syntheticmr.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3Dhistech, Epredia, Journey Biosciences, Medtronic, New Horizon Health, PHC, Union Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arcade, Cala.

Med-tech firms raising money in public or private financings, including: GT Medical, Lunaphore.

New hires and promotions in the med-tech industry, including: Endogenex.